Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
In these blogs, we explore some of the biggest topics in breast cancer research. One of those topics is how the body’s biological clock is involved in breast cancer.
Scientists have discovered a new way to potentially improve the effectiveness of breast cancer treatment by targeting a variant of a common protein
To celebrate our research successes of the past year our research communications officer, Edd, picked out his favourite discoveries and explains why they are so important.
Researchers have uncovered the key to improving immunotherapy’s ability to stop breast cancer from spreading to the lungs.
Researchers have discovered new weaknesses in a special type of cell that supports cancer cells to grow and spread around the body.
Scientists, based at the Queen Mary University of London, have discovered a new mechanism that signals which Ductal Carcinoma in Situ (DCIS) tumours may progress to invasive breast cancer. This might help avoid unnecessary treatment for some women with DCIS in the future.
PARP inhibitors like olaparib are an exciting new avenue of targeted treatment for breast cancer patients with changes to the BRCA genes. Let’s look at the journey of olaparib from first experiments in the lab until now.
Researchers have discovered weaknesses in some triple negative breast cancers that could lead to new ways to treat this form of the disease.
Researchers have identified a group of immune cells that could be targeted to develop new treatments for breast cancers that are resistant to chemotherapy.